Ketamine as a potential cognitive enhancer in neurological disorders: evidence from preclinical and clinical studies.
Saved in:
| Title: | Ketamine as a potential cognitive enhancer in neurological disorders: evidence from preclinical and clinical studies. |
|---|---|
| Authors: | Leon-Rojas JE; Cerebro, Emoción y Conducta (CEC) Research Group, School of Medicine, Universidad de Las Américas (UDLA), Quito, Ecuador., Mascialino G; Health Sciences Department, Universidad Pública de Navarra, Pamplona, Spain., Vinueza Mera L; NeurALL Research Group, Quito, Ecuador., Hinojosa-Figueroa MS; NeurALL Research Group, Quito, Ecuador., Navas Arias CF; NeurALL Research Group, Quito, Ecuador., Cadena Barberis ED; NeurALL Research Group, Quito, Ecuador., Sacks-Zimmerman A; Department of Neurological Surgery, Weill Cornell Medicine, New York, NY, United States.; Acheron Psychiatry, New York, NY, United States. |
| Source: | Frontiers in neurology [Front Neurol] 2026 Mar 30; Vol. 17, pp. 1786249. Date of Electronic Publication: 2026 Mar 30 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-2295 |
|---|---|
| DOI: | 10.3389/fneur.2026.1786249 |
